Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 4.305
-0.345 (-7.42%)
Mar 2, 2026, 5:12 PM CET
Mendus AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
264.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 3.00M | 2.99M | 49,816.67% |
| Dec 31, 2021 | 6.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sprint Bioscience AB | 167.17M |
| Bio-Works Technologies AB | 63.11M |
| Intervacc AB | 20.09M |
| Elicera Therapeutics AB | 10.86M |
| Corline Biomedical AB | 8.59M |
| Xintela AB | 2.28M |
| Lipum AB | 1.93M |